Abstract
Vascular tone is regulated by metabolic, hormonal, ionic, and neuronal mechanisms. The adrenergic nervous system plays a major role in regulating vascular tone in physiologic and pathophysiologic states. Adrenergic stimulation increases vasoconstrictor tone by stimulating alpha adrenoceptors on the plasma membrane of resistance vessels. Recent studies have provided evidence that postsynaptic receptors with pharmacological properties similar to those of alpha-1 and alpha-2 adrenoceptors are present in the systemic and pulmonary vascular beds (1–6). It has been shown in in vivo studies that pressor responses to exogenous and neurogenically released norepinephrine may be mediated by different alpha adrenoceptor subtypes (2,7,8). In the canine hindlimb and pithed rat, responses to sympathetic nerve stimulation are selectively blocked by alpha-1 adrenoceptor antagonists whereas responses to exogenous norepinephrine are attenuated by alpha-2 adrenoceptor antagonists (2,7–9). It was, therefore, postulated that alpha-1 adrenoceptors are located intrasynaptically and are preferentially activated by neurogenically released norepinephrine whereas exogenous norepinephrine acts mainly on alpha-2 receptors which are located extrasynaptically (2,7,8). There are, however, exceptions to this concept in that neuronally released norepinephrine does not preferentially activate postjunctional alpha-1 adrenoceptors in isolated human blood vessels (10).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Drew, G.M. and Whiting, S.B. Br. J. Pharmacol. 67:207–215, 1979.
Langer, S.Z., Massingham, R. and Shepperson, N.B. Clin. Sci. 59: 225s–228s, 1980.
van Meel, J.C.A., de Jonge, A., Kalkman, O., Wilffert, B., Timmermans, P.B.M.W.M. and van Zwieten, P.A. Naunyn-Schmiedeberg’s Arch. Pharmacol. 316:288–293, 1981.
Ruffolo, R.R., Jr., Nelson, W.L. and Yaden, E.L. Naunyn-Schmiedeberg’s Arch. Pharmacol. 322:93–97, 1983.
Jie, K., van Brummelen, P., Vermey, P., Timmermans, P.B.M.W.M. and van Zwieten, P.A. Circ. Res. 54:447–452, 1984.
Hyman, A.L. and Kadowitz, P.J. Am. J. Physiol. 249:H891–H898, 1985.
Yamaguchi, I. and Kopin, I.J. J. Pharmacol. Exp. Ther. 214:275–281, 1980.
Langer, S.Z. and Shepperson, N.B. J. Cardiovasc. Pharmacol. 4: S8–S13, 1982.
Holck, M. and Gerold, M. Naunyn-Schmiedeberg’s Arch. Pharmacol. 330:22–32, 1985.
Stevens, M.J. and Moulds, F.W. Circ. Res. 57:399–405, 1985.
van Meel, J.C.A., Towart, R., Kazda, S., Timmermans, P.B.M.W.M. and van Zwieten, P.A. Naunyn-Schmiedeberg’s Arch. Pharmacol. 322:34–37, 1983.
Cavero, I., Shepperson, N., Lefevre-Brog, F. and Langer, S.Z. Circ. Res. 52(I):69–76, 1983.
van Zwieten, P.A., van Meel, J.C.A. and Timmermans, P.B.M.W.M. Circ. Res. 52(I):77–80, 1983.
Armstead, W.M., Lippton, H.L., Hyman, A.L. and Kadowitz, P.J. Can. J. Physiol. Pharmacol. 62:1470–1478, 1984.
Langer, S.Z. Br. J. Pharmacol. 60:481–497, 1977.
Kostrzewa, R.M. and Jacobowitz, D.M. Pharmacol. Rev. 26:199–288, 1974.
Kadowitz, P.J., Knight, D.S., Hibbs, R.G., Ellison, J.P., Joiner, P.D., Brody, M.J. and Hyman, A.L. Circ. Res. 39:191–199, 1976.
Timmermans, P.B.M.W.M., Kwa, H.Y. and van Zwieten, P.A. Naunyn-Schmiedeberg’s Arch. Pharmacol. 319:189–193, 1979.
Timmermans, P.B.M.W.M. and van Zwieten, P.A. Naunyn-Schmiedeberg’s Arch. Pharmacol. 313:17–20, 1980.
Hyman, A.L. and Kadowitz, P.J. Am. J. Physiol, (in press), 1986.
Trendelenburg, U., Muskus, A., Fleming, W.M. and de la Sierra, B. J. Pharmacol. Exp. Ther. 138:170–180, 1962.
Lai, F.M. and Hudgins, P.M. Toxicol. Appl. Pharmacol. 32:368–376, 1975.
Vanhoutte, P.M., Verbeuren, T.J. and Webb, R.C. Physiol. Rev. 61: 151–247, 1981.
Lucchelli, A., Barbone, S.M.G. and Grana, E. Pharmacol. Res. Comm. 17:787–801, 1985.
Miyahara, H. and Suzuki, H. Br. J. Pharmacol. 86:405–416, 1985.
Hyman, A.L., Lippton, H.L. and Kadowitz, P.J. Fed. Proc. (in press), 1986.
Timmermans, P.B.M.W.M., de Jonge, A., van Meel, J.C.A., Mathy, M.J. and van Zwieten, P.A. J. Cardiovasc. Pharmacol. 5:1–11, 1983.
Towart, R. J. Cardiovasc. Pharmacol. 4:895–902, 1982.
Towart, R. and Stoepel, K. Naunyn-Schmiedeberg’s Arch. Pharmacol. 308:R18, 1979.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Lippton, H.L., Armstead, W.M., Hyman, A.L., Kadowitz, P.J. (1987). Dependence of Vasoconstrictor Responses on Extracellular Calcium. In: Beamish, R.E., Panagia, V., Dhalla, N.S. (eds) Pharmacological Aspects of Heart Disease. Developments in Cardiovascular Medicine, vol 68. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2057-9_30
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2057-9_30
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9222-7
Online ISBN: 978-1-4613-2057-9
eBook Packages: Springer Book Archive